Trem2 loss in aged macrophages treated with IL-13 enriched the genes participating in arterial diseases related to age, such as coronary artery disease and vascular calcification, indicating that the combination of macrophages and IL-13/Trem2 modulates a gene signature associated with age-dependent arterial pathologies (Fig. 6a). This evidence concerns the gene IL13 and arterial disorder.